U.S. Logistics Stock News

NYSE:EVTC
NYSE:EVTCDiversified Financial

Is There Now An Opportunity In EVERTEC (EVTC) After Prolonged Share Price Weakness

If you are wondering whether EVERTEC's current share price still reflects its true potential, or if the market has marked it down too far, this article is for you. With EVERTEC's share price at US$25.78 and share price returns of a 2.2% decline over 7 days, 13.5% decline over 30 days, 10.1% decline year to date, 21.4% decline over 1 year, 29.3% decline over 3 years and 28.1% decline over 5 years, many investors are asking what the stock is really worth now. Recent coverage has focused on...
NasdaqCM:QMMM
NasdaqCM:QMMMMedia

Assessing QMMM Holdings (QMMM) Valuation After Sharp Share Price Momentum

What recent returns say about QMMM Holdings (QMMM) QMMM Holdings (QMMM) has attracted attention after a 19.4% one day move, a return of 19.4% over the past 3 months, and a year to date gain of 87.44%. See our latest analysis for QMMM Holdings. That surge in the 1 day share price return and the latest share price of $119.4 comes on top of a 90 day share price return of 19.4% and a very large year to date share price gain. The 1 year total shareholder return is also very large, suggesting...
NasdaqGS:GOSS
NasdaqGS:GOSSBiotechs

A Look At Gossamer Bio (GOSS) Valuation As PROSERA Phase 3 Seralutinib Results Shape Next Steps

Why Gossamer Bio’s PROSERA readout matters now Gossamer Bio (GOSS) has drawn fresh attention after releasing topline Phase 3 PROSERA data for seralutinib in pulmonary arterial hypertension and scheduling a special call to review the results and potential next steps with regulators. See our latest analysis for Gossamer Bio. The unveiling of the PROSERA Phase 3 topline data and the planned FDA discussions come after a sharp reset in sentiment, with a 30 day share price return of 84.32% decline...
NYSE:RNR
NYSE:RNRInsurance

Will RenaissanceRe’s Latest Dividend Hike and Major Buybacks Change RenaissanceRe Holdings' (RNR) Capital Return Narrative?

RenaissanceRe Holdings’ board previously approved a quarterly dividend increase to US$0.41 per share from US$0.40, payable on March 31, 2026 to shareholders of record on March 13, 2026, and reported completing share repurchases totaling 3,065,414 shares across two programs for a combined US$780.48 million. The company’s three-decade pattern of annual dividend increases, paired with recently completed buybacks that retired nearly one-twentieth of its share base, highlights a sustained...
NYSE:GGG
NYSE:GGGMachinery

Graco Board Resignation Puts Focus On Governance Continuity And Oversight

Graco (NYSE:GGG) board member Brett C. Carter has resigned from the board. Carter cited personal and professional commitments for his departure, with no disagreements related to Graco reported. His resignation affects board roles tied to key areas such as audit and compensation oversight. Graco, known for its equipment for fluid handling across industrial and commercial applications, operates in a part of the market that can be influenced by broader trends in manufacturing, construction,...
NYSE:VOYG
NYSE:VOYGAerospace & Defense

Is Voyager Technologies (VOYG) Pricing Reflect A Buying Opportunity After Recent 30 Day Share Price Slide

If you are wondering whether Voyager Technologies is attractively priced or just a value trap, this article walks through what the numbers are actually saying about the stock. The share price recently closed at US$26.82, with a 3% return over the past week, a 27.7% decline over the last 30 days, and a 3.5% decline year to date, which may signal shifting views on its potential and risk. Recent news coverage around Voyager Technologies has focused on its position in the capital goods space and...
NasdaqGS:ACHC
NasdaqGS:ACHCHealthcare

Assessing Acadia Healthcare (ACHC) After A 57% One-Year Share Price Decline

If you are wondering whether Acadia Healthcare Company is attractively priced or still a value trap after a tough run, this breakdown is designed to give you a clear view of where the stock stands today. The shares last closed at US$17.38, with returns of 3.6% over 7 days, 14.1% over 30 days, 21.6% year to date, but a 57.3% decline over 1 year and a 78.4% decline over 3 years. This raises questions about how the current price lines up with underlying value. Recent news coverage has largely...
NYSE:CTRI
NYSE:CTRIConstruction

Is It Too Late To Consider Centuri Holdings (CTRI) After A 72% One-Year Rally?

If you are wondering whether Centuri Holdings' share price still reflects good value, or if the recent excitement has already been priced in, this article will walk you through what the numbers indicate about the stock. The shares last closed at US$31.24, with returns of 0.7% over 7 days, 10.0% over 30 days, 21.0% year to date and 72.1% over the past year. This has naturally raised questions about how the current price compares with underlying value. Recent news flow around Centuri Holdings...
NasdaqGM:ALVO
NasdaqGM:ALVOBiotechs

Alvotech (ALVO) Is Down 9.1% After FDA Rejects AVT05 Over Facility Issues and Legal Probe

In the past few days, law firm Kirby McInerney LLP announced it is investigating Alvotech and certain executives for potential federal securities law violations after the FDA issued a complete response letter citing a failed facility inspection for its AVT05 biologics license application. This combination of regulatory setback and investor scrutiny raises fresh questions about Alvotech’s quality controls, regulatory risk management, and disclosure practices around its biosimilar...
NYSE:MFA
NYSE:MFAMortgage REITs

MFA Financial (MFA) Valuation Check As Mixed Returns Contrast With Diverging Fair Value Estimates

MFA Financial (MFA) is on investor watch after posting annual revenue of US$325.4 million and net income of US$135.7 million, with recent returns mixed over the day, week, month and past 3 months. See our latest analysis for MFA Financial. At a share price of US$9.90, MFA Financial has seen short term share price softness alongside a positive 3 month share price return and a stronger 1 year total shareholder return of 11.27%. This suggests that recent price swings are occurring within a more...
NYSE:SPB
NYSE:SPBHousehold Products

A Look At Spectrum Brands (SPB) Valuation After Recent Share Price Momentum

Spectrum Brands Holdings (SPB) has drawn fresh attention after recent trading left the stock with a one-month return of 22% and a gain of 34.1% over the past three months, sharpening interest in its consumer brands portfolio. See our latest analysis for Spectrum Brands Holdings. That recent run sits on top of a 31.43% year to date share price return as the stock trades at US$78.91. The 1 year total shareholder return of 3.46% and 3 year total shareholder return of 33.70% suggest momentum has...
NasdaqGS:AEIS
NasdaqGS:AEISElectronic

Advanced Energy Industries Leans On Acquisitions To Reshape Growth Profile

Advanced Energy Industries (NasdaqGS:AEIS) is actively pursuing acquisitions to expand its presence, with recent deals focused on industrial and medical technology. Management has highlighted a busy acquisition pipeline and points to recent integration of new technology as evidence that its inorganic growth push is gaining traction. The company is signaling that further deals in industrial and medical markets are a priority, with the goal of reshaping its portfolio around higher value...
NYSE:OFG
NYSE:OFGBanks

Is OFG Bancorp (OFG) Still Attractive After Mixed Returns And Sector Sentiment Shifts?

If you are wondering whether OFG Bancorp at around US$41.39 is still good value or already pricing in a lot of optimism, you are asking the right question. The stock has had mixed recent returns, with a 1.2% decline over the last 7 days, an 11.4% gain over 30 days, 0.9% year to date, 2.4% over 1 year, 50.3% over 3 years and 134.3% over 5 years, which can change how investors think about both upside and risk. Recent news around OFG Bancorp has focused on its position as a US regional bank and...
NYSE:ASIC
NYSE:ASICInsurance

A Look At Ategrity Specialty Insurance Company Holdings (ASIC) Valuation After Recent Share Price Surge

Ategrity Specialty Insurance Company Holdings (ASIC) has drawn fresh attention after a sharp recent move in its share price, with the stock up 6.1% over the past day and 32.7% in the past week. See our latest analysis for Ategrity Specialty Insurance Company Holdings. The recent surge in Ategrity Specialty Insurance Company Holdings’ share price, including a 32.7% 7 day share price return and a 23.97% 90 day share price return, suggests short term momentum is building while year to date...
NYSE:APAM
NYSE:APAMCapital Markets

Artisan Partners Expands Alternatives As Valuation Discount And Risks Persist

Artisan Partners Asset Management (NYSE:APAM) is expanding its alternatives platform and pursuing new partnerships to support growth. The company is pushing ahead with these initiatives while facing regulatory headwinds and changing client preferences. This shift in focus is intended to broaden its actively managed offering as more capital moves toward passive products. Artisan Partners has built its business around actively managed strategies, and the move into more alternative offerings...
NasdaqGS:LILA
NasdaqGS:LILATelecom

Liberty Latin America Rebuilds Jamaica Network And Seeks Value In 5G Shift

Liberty Latin America is rebuilding its network in Jamaica after Hurricane Melissa while keeping subscriber and B2B growth on track. The company is rolling out 5G standalone mobile services in partnership with Ericsson. Liberty Latin America is working with AWS on cloud and AI capabilities to support its telecom and enterprise offerings. Liberty Latin America, ticker NasdaqGS:LILA, is drawing attention as it works through major operational disruption while still adding postpaid mobile...
NasdaqGS:WING
NasdaqGS:WINGHospitality

Wingstop Tariffs And Labor Scrutiny Test Valuation And Growth Story

Wingstop (NasdaqGS:WING) is facing new global tariffs announced by the Trump administration, which affect international trade and input costs. The company is also under public scrutiny after a former employee publicly alleged issues with labor and management practices. Social media conversations have amplified these accusations, raising questions for customers, employees, and investors. Wingstop, known for its chicken wing restaurants and franchise model, relies on international supply...
NasdaqGS:WGS
NasdaqGS:WGSHealthcare

GeneDx Holdings (WGS) Q4 Loss Of US$17.7 Million Tests Bullish Profitability Narrative

GeneDx Holdings (WGS) closed out FY 2025 with Q4 revenue of US$121.0 million and a basic EPS loss of US$0.61, alongside net income excluding extraordinary items of a US$17.7 million loss. Over recent quarters the company has seen revenue move from US$95.6 million in Q4 2024 to US$121.0 million in Q4 2025, while quarterly basic EPS has ranged from a loss of US$0.31 in Q3 2024 to a gain of US$0.38 in Q2 2025 and back to a loss of US$0.61 in the latest period. This sets up a story in which...
NasdaqGS:BEAM
NasdaqGS:BEAMBiotechs

Beam Therapeutics Taps US$500m Non Dilutive Debt To Back Risto Cel

Beam Therapeutics entered a long term, non dilutive financing agreement with Sixth Street to support the potential launch of its sickle cell gene therapy. The deal provides access to up to $500 million in capital tied to Beam’s commercial plans for this program. The agreement focuses on funding potential product launch and commercialization activities rather than issuing new equity. For investors watching NasdaqGS:BEAM, this financing move comes with the stock trading around $28.33 and a...
NYSE:ELS
NYSE:ELSResidential REITs

Is Equity LifeStyle Properties (ELS) Price Still Reasonable After Recent DCF Upside Signal

Wondering if Equity LifeStyle Properties at around US$67.96 is offering fair value right now, or if the price is running ahead of reality? The stock has returned 0.2% over the past week, 6.2% over the last month, 13.7% year to date, 4.8% over 1 year, 8.0% over 3 years and 26.3% over 5 years. This provides a mix of short and longer term outcomes to weigh up. Recent news coverage has focused on Equity LifeStyle Properties as a large US listed real estate owner and operator, with investors...
NasdaqGM:AXSM
NasdaqGM:AXSMPharmaceuticals

Axsome Therapeutics Q4 Revenue Surge Tests Bulls’ Profitability Narrative

Axsome Therapeutics (AXSM) closed FY 2025 with Q4 revenue of US$196.0 million and a basic EPS loss of US$0.56, alongside a net income loss of US$28.6 million, keeping profitability firmly in focus for investors. The company has seen quarterly revenue move from US$118.8 million in Q4 2024 to US$196.0 million in Q4 2025, while basic EPS has shifted from a loss of US$1.54 to a loss of US$0.56 over the same period. This frames a story where top line scale is running ahead of bottom line progress...
NYSE:NPO
NYSE:NPOMachinery

How Investors Are Reacting To Enpro (NPO) 2026 Growth Targets, Dividend Bump, And M&A Capacity

Enpro Inc. reported past fourth-quarter 2025 sales of US$295.4 million and a net loss of US$32 million, issued 2026 revenue growth guidance of 8% to 12%, and signaled ongoing capacity for acquisitions under its Enpro 3.0 framework. The company is pairing a small quarterly dividend increase to US$0.32 per share with plans to pursue acquisitions that add technology, talent, and process expertise in its key growth areas. We’ll now examine how Enpro’s 2026 revenue guidance and acquisition...
NYSE:PFGC
NYSE:PFGCConsumer Retailing

Is Performance Food Group (PFGC) Still Attractive After Its Recent Share Price Gains

If you are wondering whether Performance Food Group's share price still offers value at around US$95.79, you are not alone. Many investors are asking the same question before making their next move. The stock has seen a 2.3% decline over the last 7 days, a 2.0% gain over 30 days, and is up 8.8% year to date, with a 15.6% return over 1 year, 65.2% over 3 years and 70.9% over 5 years. These figures may influence how you think about its risk and reward trade off. Recent company updates and...
NYSE:KEX
NYSE:KEXShipping

Is Kirby (KEX) Fairly Priced After Doubling Over Five Years?

If you are wondering whether Kirby's current share price truly reflects its underlying value, you are not alone. That is exactly what this article will unpack. With the stock at US$128.46 after a 2.8% gain over the last 7 days, a flat 0.2% move over 30 days, and returns of 14.8% year to date, 27.3% over 1 year, 76.4% over 3 years and 100.0% over 5 years, many investors are asking what is already priced in. Recent attention on Kirby has largely centered on its role in the U.S. marine...